CHDI Foundation
Business Services · New York, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
350 7th Ave Rm 200, New York City, New Y...Phone Number
(212) 239-9300Website
www.chdifoundation.orgRevenue
$16.6 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
2
1
2
1
1
About CHDI Foundation
CHDI Foundation is dedicated to accelerating therapeutic development for Huntington's Disease. They offer a range of resources including preclinical research, data sharing informatics, and tools for researchers, as well as funding partnerships to stimulate academic collaborations. The foundation engages with pharmaceutical and biotechnology companies to foster new ideas and partnerships through conferences and publications. Their target clients include researchers, academic institutions, and organizations focused on Huntington's Disease.Explore more
CHDI Foundation Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is CHDI Foundation your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if CHDI Foundation has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when CHDI Foundation launches new products
Check out if CHDI Foundation is spiking on competitors!
CHDI Foundation, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once CHDI Foundation has new funding data
Earning: See what the market has to say on CHDI Foundation recently announced quarterly report
Click to see if CHDI Foundation had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at CHDI Foundation
Recommended Actions
Find VP level buyers at CHDI Foundation
Find more new buyers
Compare Similar Companies to CHDI Foundation
Compare insights from companies similar to CHDI Foundation, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
CHDI Foundation is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
CHDI Foundation is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about CHDI Foundation.
CHDI Foundation Tech Stack
A closer look at the technologies used by CHDI Foundation
See more technologies
Most Recent Scoops
Hiring Plans
CHDI Foundation has more open roles in Medical & Health than it has had at any time in the past 12 months. Areas of expertise include: Neurological Disorders, Clinical Research, Healthcare Services, and Clinical Medicine.
Hiring Plans
Hiring Plans
CHDI Foundation has more open roles in Medical & Health than it has had at any time in the past 12 months.
Hiring Plans
Left Company
Larry Park, Director, In vivo Research, has left the organization.
Personnel Moves, Left Company
Project
we have identified upcoming IT initiatives surrounding the organization's clinical systems. Richard Chen currently serves as Director, Genome Engineering & Drug Discovery.
Engineering, Clinical Systems
Project
Upgrade, Collaboration/Web Apps, Engineering, Product Development, Product Management
CHDI Foundation News & Media
Alchemab and Medicines Discovery Catapult to develop landmark novel antibody therapy for Huntington’s disease
LONDON--(BUSINESS WIRE)--Alchemab, a biotech company developing novel therapeutics for patients with hard-to-treat diseases by harnessing the power of naturally protective antibodies, has been awarded a UK Biomedical Catalyst early award grant from Innovate UK to support the development of a novel disease-modifying antibody therapy for Huntington’s disease (HD). The grant will support Alchemab in its pioneering collaboration with Medicines Discovery Catapult. Alchemab has a unique target-agnostMolecular Design Platform Accelerating Research For Huntington's Disease
SANTA FE, N.M., & NEW YORK, July 30, 2020 /PRNewswire/ -- OpenEye Scientific (OpenEye) and CHDI Foundation (CHDI) today announced a research collaboration to identify novel small-molecule therapeutics for Huntington's disease (HD) utilizing Orion, OpenEye's cloud-native molecular design...Wave Life Sciences to Present Preclinical In Vivo and In Vitro Data for SNP3-Targeting Huntington’s Disease Program at CHDI Foundation’s 15th Annual HD Therapeutics Conference
CAMBRIDGE, Mass., Feb. 18, 2020 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage genetic medicines company committed to delivering life-changing treatments for people battling devastating diseases, today announced that it will present preclinical data from its SNP3-targeting Huntington’s disease (HD) program at the CHDI Foundation’s 15th Annual Huntington’s Disease Therapeutics Conference, being held February 24-27, 2020, in Palm Springs, California. The poster presentCharles River Laboratories and CHDI Foundation Extend Huntington’s Disease Collaboration
WILMINGTON, Mass.--(BUSINESS WIRE)--$CRL #LIFEatCRL--Charles River and CHDI Foundation today announced a five-year extension of their ongoing collaboration.
Read more news
Top Business Services Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding CHDI Foundation
Sign Up For FreeTo access detailed company insights
CHDI Foundation is dedicated to accelerating therapeutic development for Huntington's Disease. They offer a range of resources including preclinical research, data sharing informatics, and tools for researchers, as well as funding partnerships to stimulate academic collaborations. The foundation engages with pharmaceutical and biotechnology compani... Read More
